Artemis Medicare Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2025 ,inter alia, to consider and approve the Un-audited Financial ....
ARTEMISMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Artemis Medicare Services has informed the exchanges that its Board of Directors will meet on November 11, 2025, to consider and approve the un-audited standalone and consolidated financial results for the quarter and half year ended September 30, 2025. As per SEBI listing regulations, this is a standard advance intimation regarding the upcoming results announcement. The trading window for dealing in company securities has been closed since October 1, 2025, and will reopen 48 hours after the results are declared, i.e., on November 13, 2025. No financial details or numbers have been disclosed in this filing — only the meeting schedule.
This is a routine regulatory intimation and does not impact the stock price directly. Investors should wait for the actual results on November 11 to assess Q2 FY26 performance and any management commentary.